Santhera Pharmaceuticals Holding AG (S3F0) Stock Price & News

All values in CHF	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	26.59M	26.59M	24.16M	24.16M
Cost of goods sold	14.94M	14.94M	15.01M	15.01M
Cost of revenue	14.94M	14.94M	15.01M	15.01M
Research and development expenses	5.26M	5.26M	4.96M	4.96M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	7.57M	7.57M	7.55M	7.55M
Operating expense	12.73M	12.73M	12.44M	12.44M
Total operating expenses	27.67M	27.67M	27.45M	27.45M
Operating income	-1.08M	-1.08M	-3.28M	-3.28M
Other non operating income	-577.00K	-577.00K	-1.77M	-1.77M
EBT including unusual items	-5.15M	-5.15M	-10.75M	-10.75M
EBT excluding unusual items	-5.20M	-5.20M	-10.75M	-10.75M
Income tax expense	55.00K	55.00K	15.50K	15.50K
Effective tax rate	-1.07%	-1.07%	-0.14%	-0.14%
Other operating expenses	-102.00K	-102.00K	-66.00K	-66.00K
Net income	-5.20M	-5.20M	-10.76M	-10.76M
Net profit margin	-19.57%	-19.57%	-44.54%	-44.54%
Earnings per share	-	-	-	-
Interest and investment income	27.00K	27.00K	-	-
Interest expense	-3.38M	-3.38M	-5.27M	-5.27M
Net interest expenses	-3.35M	-3.35M	-5.27M	-5.27M
Depreciation and amortization charges	-	-	-	-
EBITDA	35.00K	35.00K	-1.85M	-1.85M
Gain or loss from assets sale	-	-	-	-

Ask anything